A series of podcasts featuring experts who discuss the application of IL-1 antagonist anakinra within its licensed indications. Hear from:
Please register for Sobi Pro to view these videos.
Explore the 2024 EULAR/PReS recommendations, including a unified perspective on Still's disease, guidelines for diagnosis and prioritising early intervention.
Please register for Sobi Pro to view this content.
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search MHRA Yellow Card in the Google Play or Apple App Store (for United Kingdom) and www.hpra.ie (for Republic of Ireland). Adverse events should also be reported to Swedish Orphan Biovitrum Ltd at [email protected] or Telephone +44 (0) 800 111 4754